PCM
CORV

Prelude Capital Management’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Prelude Capital Management’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-108,112
Closed -$216K – 2600
2019
Q3 		$216K Hold
108,112
– – 0.03% 742
2019
Q2 		$234K Sell
108,112
-14,705
-12% -$37.6K 0.02% 686
2019
Q1 		$388K Buy
122,817
+54,552
+80% +$176K 0.04% 548
2018
Q4 		$170K Buy
+68,265
New +$227K 0.02% 780
2015
Q3 		– Sell
-3,000
Closed -$28K – 1968
2015
Q2 		$28K Buy
+3,000
New +$28K ﹤0.01% 1295
2015
Q1 		– Sell
-600
Closed -$6K – 2335
2014
Q4 		$6K Buy
+600
New +$5.05K ﹤0.01% 1833

Other funds holding CORV

TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return